Adaptive Biotechnologies Corporation (ADPT)

NASDAQ

$25,29

$-0,28

(-1,10%)

After-Hours

Adaptive Biotechnologies Corporation (ADPT) Live Price Chart

Last updated: ⁦2026-10-13 21:43:40⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Adaptive Biotechnologies Corporation (ADPT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $25,29, with a market capitalization of $4,23B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $12,00 to $30,74. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$4,23B
Open	$25,38
Day's High	$123,97
Day's Low	$0,90
Previous Close	$25,57
Volume	1,45M
Average Volume	2,40M
P/E Ratio	--
52-Week High	$30,74
52-Week Low	$12,00
Dividend Yield	--
Earnings Date	--

Adaptive Biotechnologies Corporation (ADPT) After-Hours Stock Price

Adaptive Biotechnologies Corporation (ADPT) is trading at $25,39 in after-hours trading as of 2026-10-13 21:29:00, down 0,70% ($0,18) from the regular-session close of $25,57.

After-hours trading shows how investors are pricing ADPT after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

Adaptive Biotechnologies Corporation (ADPT) 7-Day Stock Price Change

Over the past seven days, Adaptive Biotechnologies Corporation (ADPT) moved from $28,35 to $25,29, representing a decline of 10,80% ($3,06).

The stock traded between $24,76 and $30,74 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2,14 million shares, down versus the previous seven-day period, indicating lower trading activity.

ADPT 52-Week Price Position

Position in Range: 70,9%

52W Low$12,00

52W High$30,74

ADPT is currently trading at $25,29, placing it 70,9% of the way from its 52-week low of $12,00 to its 52-week high of $30,74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Adaptive Biotechnologies Corporation (ADPT)?

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Adaptive Biotechnologies Corporation Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	624
Exchange	NASDAQ
Company Website	https://www.adaptivebiotech.com

How to Buy Adaptive Biotechnologies Corporation (ADPT) Stock on MEXC

Eligible investors can buy real shares of Adaptive Biotechnologies Corporation (ADPT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for ADPT and Place Your Order

Open the RealStocks trading page and search for ADPT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Adaptive Biotechnologies Corporation (ADPT) stock price today?

Adaptive Biotechnologies Corporation (ADPT) is currently trading at $ 25,29, down 1,10% ($0,28) from the previous close of $ 25,57. Intraday prices update in real time during regular trading hours.

2.Is ADPT stock going up or down today?

As of 2026-10-13 21:29:00, ADPT is trading at $ 25,29, down 1,10% ($0,28) from its previous close of $ 25,57. The stock has traded between $ 0,90 and $ 123,97 during today’s regular session. Past price movements do not guarantee future results.

3.What is ADPT pre-market price?

As of 2026-10-13 21:29:00, ADPT is trading at $ 25,11 in pre-market trading, down 1,82% ($0,46) from the previous close of $ 25,57. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is ADPT after-hours price?

As of 2026-10-13 21:29:00, ADPT is trading at $ 25,39 in after-hours trading, down 0,70% ($0,18) from the regular-session close of $ 25,57. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is ADPT stock trading now?

ADPT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does ADPT sit relative to its 52-week high and low?

Over the past 52 weeks, ADPT has traded between a low of $ 12,00 and a high of $ 30,74. At $ 25,29, the stock is positioned 70,9% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Adaptive Biotechnologies Corporation in?

Adaptive Biotechnologies Corporation (ADPT) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Adaptive Biotechnologies Corporation's market capitalization and where is it listed?

Adaptive Biotechnologies Corporation is listed on the NASDAQ exchange with a market capitalization of $ 4,23B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is ADPT valued in terms of P/E ratio and EPS?

ADPT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0,40. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Adaptive Biotechnologies Corporation pay a dividend?

Adaptive Biotechnologies Corporation pays an indicated annual cash dividend of $ 0,00 per share, with a current dividend yield of 0,00% based on the latest share price. Dividend policies are subject to change at the board's discretion.